AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 14,690
-12 (-0.08%)
Mar 31, 2026, 5:15 PM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 227.84 billion as of March 31, 2026. Its market cap has increased by 24.44% in one year.
Market Cap
227.84B
Enterprise Value
245.70B
Revenue
43.64B
Ranking
n/a
PE Ratio
30.23
Stock Price
14,690.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 227.84B, an increase of 4,907.01%. That is a compound annual growth rate of 12.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 227.84B | 6.54% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 82.48B |
| Haleon | 33.56B |
| Smith & Nephew | 10.20B |
| Convatec Group | 4.27B |
| Hikma Pharmaceuticals | 2.72B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.61B |
| Oxford Nanopore Technologies | 1.03B |